|
DK621789D0
|
|
Agents that enhance transdermal penetration
|
|
US4954448A
|
|
Modulation of adenylate cyclase response
|
|
US4886783A
|
|
Penetration enhancers for transdermal delivery of systemic agents
|
|
US4931270A
|
|
Method for detecting dopaminergic diseases using fluorine-18 radiolabelled D2 dopamine receptor ligands
|
|
US4917688A
|
|
Bandage for transdermal delivery of systemically-active drug
|
|
IE881880L
|
|
Melatonin analogs
|
|
US4885308A
|
|
Method and compositions for treatment of parkinsonism syndrome in mammals
|
|
US4879275A
|
|
Penetration enhancers for transdermal delivery of systemic agent
|
|
IE881231L
|
|
N6-substituted-9-methyladenines
|
|
US4908262A
|
|
Article with microbiocidal solution
|
|
US4912223A
|
|
1,4-Dihydropyridines
|
|
AU1491588A
|
|
Bandage for transdermal delivery of drugs
|
|
EP0268219A1
|
|
Penetration enhancers for transdermal delivery of systemic agents
|
|
EP0268218A2
|
|
Penetration enhancers for transdermal delivery of systemic agents
|
|
CA1319613C
|
|
Penetration enhancers for transdermal delivery of systemic agents
|
|
US4920101A
|
|
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
|
WO8802361A1
|
|
Acid catalyzed process
|
|
EP0254989A2
|
|
Substituted 2-Aminotetralins
|
|
EP0257285A2
|
|
Method and compositions for reducing the intraocular pressure of mammals
|
|
CA1308352C
|
|
Compositions comprising 1-oxohydrocarbyl-substituted azacyclohexanes
|
